Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMoonpig Gr Regulatory News (MOON)

Share Price Information for Moonpig Gr (MOON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 153.20
Bid: 154.00
Ask: 154.60
Change: -3.80 (-2.42%)
Spread: 0.60 (0.39%)
Open: 155.00
High: 157.80
Low: 153.20
Prev. Close: 157.00
MOON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

5 Feb 2021 16:37

RNS Number : 2114O
J.P. Morgan Securities PLC.
05 February 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL.

 

Moonpig Group plc (the "Company")

End of Stabilisation Notice 

 

Further to the pre-stabilisation period announcement dated 2 February 2021, J.P. Morgan Securities plc (which conducts its UK investment banking activity as J.P. Morgan Cazenove) (contact: Beau Freker; telephone: +44 207 742 4000) hereby gives notice that no stabilisation (within the meaning of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 as such legislation forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018) was undertaken by the Stabilising Manager named below in relation to the offer of the following securities and is terminating the stabilisation period early.

 

 

The securities:

Issuer:

Moonpig Group plc

Securities:

Ordinary shares of the Issuer (ISIN:GB00BMT9K014)

Offer size:

140,355,981 (excluding the Over-allotment Option)

Offer price:

350 pence

Stabilisation:

Stabilising Manager(s):

J.P. Morgan Securities plc (which conducts its UK investment banking activity as J.P. Morgan Cazenove), 25 Bank Street, Canary Wharf, London, E14 5JP, United Kingdom

Stabilisation period

Tuesday 2 February 2021 - Friday 5 February 2021

Maximum size of Over-allotment facility:

Up to 14,035,599 shares

Stabilisation trading venue:

London Stock Exchange

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Company in any jurisdiction.

 

This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States of America (the "United States"), Australia, Canada, Japan or any other jurisdiction where such release, publication or distribution would be unlawful. This announcement does not contain or constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or any other jurisdiction where such an offer would be unlawful.

 

The securities discussed herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States. The securities may not be offered, sold, resold, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada or Japan and, subject to certain exceptions, may not be offered or sold within Australia, Canada or Japan or to any national, resident or citizen of Australia, Canada or Japan. The release, publication or distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions.

This announcement is only addressed to and directed at specific addressees who: (A) if in member states of the European Economic Area (the "EEA"), are persons who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) ("Qualified Investors"); and (B) if in the United Kingdom, are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018 who are: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order; or (C) are other persons to whom it may otherwise lawfully be communicated (all such persons referred to in (B) and (C) together being "Relevant Persons"). This announcement must not be acted or relied on (i) in the United Kingdom, by persons who are not Relevant Persons and (ii) in any member state of the EEA by persons who are not Qualified Investors. Any investment activity to which this announcement relates (i) in the United Kingdom is available only to, and may be engaged in only with, Relevant Persons; and (ii) in any member state of the EEA is available only to, and may be engaged only with, Qualified Investors.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEASASESKFEFA
Date   Source Headline
12th Jun 20249:00 amPRNHolding(s) in Company
12th Jun 20249:00 amPRNHolding(s) in Company
3rd Jun 20241:00 pmPRNHolding(s) in Company
31st May 20249:00 amPRNHolding(s) in Company
29th May 20243:00 pmPRNHolding(s) in Company
23rd May 20243:00 pmPRNHolding(s) in Company
1st May 20243:00 pmPRNTotal Voting Rights
29th Apr 20243:00 pmPRNHolding(s) in Company
29th Apr 20243:00 pmPRNHolding(s) in Company
29th Apr 202411:00 amPRNSection 430(2b) statement
26th Apr 20243:00 pmPRNDirector Declaration
26th Apr 20241:00 pmPRNDirectorate Change
25th Apr 20243:00 pmPRNHolding(s) in Company
24th Apr 20247:00 amPRNNotice of Results
17th Apr 20247:00 amPRNAdditional listing
2nd Apr 20243:00 pmPRNHolding(s) in Company
14th Mar 20247:00 amPRNTrading Update and New Revolving Credit Facility
8th Feb 20241:00 pmPRNDirector Declaration
19th Jan 20241:00 pmPRNTotal Voting Rights
16th Jan 20243:00 pmPRNHolding(s) in Company
3rd Jan 20249:00 amPRNNotice of Results
22nd Dec 20239:00 amPRNBlocklisting - Interim Review
5th Dec 20237:00 amRNSHalf-year results announcement
6th Nov 20231:00 pmPRNHolding(s) in Company
26th Oct 20233:00 pmPRNHolding(s) in Company
25th Oct 202311:00 amPRNHolding(s) in Company
24th Oct 202311:00 amPRNNotice of Results
26th Sep 20233:00 pmPRNHolding(s) in Company
20th Sep 202311:00 amPRNDirector/PDMR Shareholding
19th Sep 20233:00 pmPRNResult of AGM
19th Sep 20239:00 amPRNHolding(s) in Company
19th Sep 20237:00 amRNSAGM Trading Update
16th Aug 20239:00 amPRNHolding(s) in Company
11th Aug 20239:00 amPRNNotice of Trading update
12th Jul 20232:00 pmPRNAnnual Report and Accounts and Notice of Annual General Meeting 2023
5th Jul 20231:00 pmPRNDirector/PDMR Shareholding
5th Jul 20231:00 pmPRNDirector/PDMR Shareholding
4th Jul 20239:00 amPRNHolding(s) in Company
3rd Jul 20233:00 pmPRNTotal Voting Rights
3rd Jul 20233:00 pmPRNDirector/PDMR Shareholding
3rd Jul 20233:00 pmPRNDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFinal Results
20th Jun 20237:00 amRNSBlock listing application
6th Jun 20234:00 pmRNSNotice of Results
22nd May 202311:00 amRNSHolding(s) in Company
15th May 202311:00 amRNSHolding(s) in Company
5th May 20239:00 amRNSHolding(s) in Company
4th May 20239:00 amRNSHolding(s) in Company
2nd May 20239:00 amRNSTotal Voting Rights
28th Apr 20239:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.